FIG. 1.
Cancer-specific survival (CSS) in 41 patients in the study cohort. Five- and 10-year CSS rates were 55.9% and 43.4%, respectively.
Cancer-specific survival (CSS) in 41 patients in the study cohort. Five- and 10-year CSS rates were 55.9% and 43.4%, respectively.